Cargando…

Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007

Laboratory and epidemiologic evidence suggests that pathogen-specific factors may affect multidrug-resistant (MDR) tuberculosis (TB) transmission and pathogenesis. To identify demographic and clinical characteristics of MDR TB case clustering and to estimate the effect of specific isoniazid resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, John Z., Kim, Elizabeth Y., Lin, S.-Y. Grace, Cattamanchi, Adithya, Oh, Peter, Flood, Jennifer, Hopewell, Philip C., Kato-Maeda, Midori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294976/
https://www.ncbi.nlm.nih.gov/pubmed/20735924
http://dx.doi.org/10.3201/eid1609.100253
_version_ 1782225543802912768
author Metcalfe, John Z.
Kim, Elizabeth Y.
Lin, S.-Y. Grace
Cattamanchi, Adithya
Oh, Peter
Flood, Jennifer
Hopewell, Philip C.
Kato-Maeda, Midori
author_facet Metcalfe, John Z.
Kim, Elizabeth Y.
Lin, S.-Y. Grace
Cattamanchi, Adithya
Oh, Peter
Flood, Jennifer
Hopewell, Philip C.
Kato-Maeda, Midori
author_sort Metcalfe, John Z.
collection PubMed
description Laboratory and epidemiologic evidence suggests that pathogen-specific factors may affect multidrug-resistant (MDR) tuberculosis (TB) transmission and pathogenesis. To identify demographic and clinical characteristics of MDR TB case clustering and to estimate the effect of specific isoniazid resistance–conferring mutations and strain lineage on genotypic clustering, we conducted a population-based cohort study of all MDR TB cases reported in California from January 1, 2004, through December 31, 2007. Of 8,899 incident culture-positive cases for which drug susceptibility information was available, 141 (2%) were MDR. Of 123 (87%) strains with genotype data, 25 (20%) were aggregated in 8 clusters; 113 (92%) of all MDR TB cases and 21 (84%) of clustered MDR TB cases occurred among foreign-born patients. In multivariate analysis, the katG S315T mutation (odds ratio 11.2, 95% confidence interval 2.2–∞; p = 0.004), but not strain lineage, was independently associated with case clustering.
format Online
Article
Text
id pubmed-3294976
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-32949762012-03-07 Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007 Metcalfe, John Z. Kim, Elizabeth Y. Lin, S.-Y. Grace Cattamanchi, Adithya Oh, Peter Flood, Jennifer Hopewell, Philip C. Kato-Maeda, Midori Emerg Infect Dis Research Laboratory and epidemiologic evidence suggests that pathogen-specific factors may affect multidrug-resistant (MDR) tuberculosis (TB) transmission and pathogenesis. To identify demographic and clinical characteristics of MDR TB case clustering and to estimate the effect of specific isoniazid resistance–conferring mutations and strain lineage on genotypic clustering, we conducted a population-based cohort study of all MDR TB cases reported in California from January 1, 2004, through December 31, 2007. Of 8,899 incident culture-positive cases for which drug susceptibility information was available, 141 (2%) were MDR. Of 123 (87%) strains with genotype data, 25 (20%) were aggregated in 8 clusters; 113 (92%) of all MDR TB cases and 21 (84%) of clustered MDR TB cases occurred among foreign-born patients. In multivariate analysis, the katG S315T mutation (odds ratio 11.2, 95% confidence interval 2.2–∞; p = 0.004), but not strain lineage, was independently associated with case clustering. Centers for Disease Control and Prevention 2010-09 /pmc/articles/PMC3294976/ /pubmed/20735924 http://dx.doi.org/10.3201/eid1609.100253 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research
Metcalfe, John Z.
Kim, Elizabeth Y.
Lin, S.-Y. Grace
Cattamanchi, Adithya
Oh, Peter
Flood, Jennifer
Hopewell, Philip C.
Kato-Maeda, Midori
Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title_full Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title_fullStr Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title_full_unstemmed Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title_short Determinants of Multidrug-Resistant Tuberculosis Clusters, California, USA, 2004–2007
title_sort determinants of multidrug-resistant tuberculosis clusters, california, usa, 2004–2007
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3294976/
https://www.ncbi.nlm.nih.gov/pubmed/20735924
http://dx.doi.org/10.3201/eid1609.100253
work_keys_str_mv AT metcalfejohnz determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT kimelizabethy determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT linsygrace determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT cattamanchiadithya determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT ohpeter determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT floodjennifer determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT hopewellphilipc determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007
AT katomaedamidori determinantsofmultidrugresistanttuberculosisclusterscaliforniausa20042007